B and C domain containing tenascin-C: urinary markers for invasiveness of urothelial carcinoma of the urinary bladder?

By Richter Petra   Tost Markus   Franz Marcus   Altendorf-Hofmann Annelore   Junker Kerstin   Borsi Laura   Neri Dario   Kosmehl Hartwig   Wunderlich Heiko   Berndt Alexander  

Journal of Cancer Research and Clinical Oncology, Vol. 135, Iss. 10, 2009-10 ,pp. : 1351-1358

Springer Publishing Company

Access to resources Recommend Favorite

The Optimal Diagnosis of Urothelial Carcinoma of the Bladder

By  

Current Cancer Therapy Reviews, Vol. 7, Iss. 4, 2011-11 ,pp. : 267-271

Bentham Science Publishers

Access to resources Recommend Favorite

Role of the angiogenic components, VEGFA, FGF2, OPN and RHOC, in urothelial cell carcinoma of the urinary bladder

By          

Oncology Reports, Vol. 28, Iss. 4, 2012-01 ,pp. : 1159-1166

Spandidos Publications

Access to resources Recommend Favorite

Semi-quantitative analysis of telomerase activity of exfoliated cells in urine of patients with urothelial cancers: - A potential marker of bladder transitional cell carcinoma in bladder washes

By Akao T.   Kakehi Y.   Wu X.-X.   Kinoshita H.   Takahashi T.   Ogawa O.   Kato T.   Yoshida O.  

Urologic Oncology: Seminars and Original Investigations, Vol. 3, Iss. 4, 1997-07 ,pp. : 118-124

Elsevier

Access to resources Recommend Favorite

Overexpression of DJ-1 and HSP90α, and loss of PTEN associated with invasive urothelial carcinoma of urinary bladder: Possible prognostic markers

By      

Oncology Letters, Vol. 3, Iss. 3, 2012-01 ,pp. : 507-512

Spandidos Publications

Access to resources Recommend Favorite